HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ:IPXL) today announced that it is commencing shipment of its authorized generic version of Adderall XR® Capsules, 5mg, 10mg, 15mg, 20mg, 25mg and 30mg, through Global Pharmaceuticals, Impax’s generic division. Shire Pharmaceuticals markets Adderall XR® for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
